Neurology Today in 5 podcast

Cognitive Decline Biomarker, Tirofiban's Impact on Stroke, Peer Reviewers' Use of Artificial Intelligence

0:00
4:58
Retroceder 15 segundos
Avanzar 15 segundos

In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about a blood test that could predict cognitive decline before pathological signs, the use of tirofiban after tenecteplase for stroke, and the role of artificial intelligence in peer review.

Otros episodios de "Neurology Today in 5"